Get startedLog in
    Picture of NovaBridge Biosciences logo

    NBP — NovaBridge Biosciences Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for NovaBridge Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    R2022
    December 31st
    R2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:
    fx
    Final
    fx
    Final    		FinalFinalFinal
    Net Income/Starting Line68.3-361-371-208-22.2
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items27.414718561.9-55.4
    Discontinued Operations
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-34.961.217.1-37.1-2.81
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities62.8-151-166-182-80.2
    Capital Expenditures-1.16-4.64-2.09-0.164-0.048
    Purchase of Fixed Assets
    Other Investing Cash Flow Items-28.1-10870.111.1-158
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-29.3-1136810.9-158
    Financing Cash Flow Items404-21.52.819.91-4.17
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities49992.16.721.67-4.51
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash517-191-77.3-165-242